M&A Science

Kison Patel
M&A Science
Último episodio

418 episodios

  • M&A Science

    The Nordic Compounder Playbook: How Jörgen Wigh Runs 85 Companies With 22 HQ Staff and No Integration

    04/06/2026 | 40 min
    Jörgen Wigh, CEO of Lagercrantz Group
    Lagercrantz Group has completed 90+ acquisitions over 20 years and never sold one. CEO Jörgen Wigh runs 85 niche B2B companies under a 22-person headquarters with no integration, no exits, and no value realization targets.
    This is Part 2 of 2. Part 1 covers the deal model, while Part 2 is the operating culture. Jörgen gets into how 85 autonomous companies are governed without a matrix structure, why this model exists almost exclusively in the Nordics, what makes a founder walk away from a signed deal twice, why Lagercrantz deliberately targets a 10% failure rate, and what he would do differently starting from scratch today.
    What You'll Learn
    How Lagercrantz governs 85 autonomous companies with 22 people at headquarters
    Why the person who sources the deal always stays on the board post-close
    Why the Nordic compounder model exists here and almost nowhere else
    What makes a founder walk away from a signed deal twice
    What a 10% deal failure rate looks like when it's working as intended
    Why building this from scratch today takes at least a decade
    How cross-border deals get done when the legal contracts run 30 pages instead of 300
    If you want to know how your team stacks up against the discipline Jörgen described across both episodes, take the M&A Competency Assessment.
    ____________________
    This episode of M&A Science is presented by DealRoom.
    DealRoom just launched the only MCP server built for Buyer-Led M&A™ — so your AI and your deal data finally work together. Connect Claude, ChatGPT, or Copilot directly to DealRoom and let your AI read your pipeline, analyze due diligence documents, and automatically write findings back. 
    See for yourself: dealroom.net/mcp
    ____________________
    Episode Chapters
    [01:14] Introduction and Part 1 recap
    [03:54] Deal governance: go/no-go process and board sign-off
    [04:31] No handoffs: why the deal sourcer stays on the board post-close
    [04:59] HQ structure: 22 people distributed across geographies
    [07:05] Why so many compounder platforms come from the Nordics
    [07:23] The cultural reasons: flat hierarchy, financial transparency, equality
    [09:19] Nordic management style versus US hierarchy
    [13:53] Cross-border deal friction: SPA length and legal complexity
    [24:43] Programmatic serial acquirer versus roll-up
    [25:18] The 100-day plan question: when Lagercrantz uses one and when it doesn't
    [25:59] The Bergman & Beving spinout ecosystem: six listed companies
    [26:45] Jörgen's role at Bergman & Beving and how conflicts are managed
    [29:57] Geographic expansion: Germany, Netherlands, DACH, Northern Italy
    [31:30] Starting from scratch today: why programmatic takes 10 years
    [33:01] EPS as the true long-term performance driver, not stock price
    [33:52] The perpetual ownership model and why it attracts certain sellers
    [34:17] The founder who backed out twice, patience won the deal
    [35:36] Failure rate: targeting 10%, what drives deals off course
  • M&A Science

    The Nordic Compounder Playbook: How Lagercrantz Bought 90 Companies and Never Sold One

    28/05/2026 | 42 min
    Jörgen Wigh, CEO of Lagercrantz Group
    Jörgen Wigh has been CEO of Lagercrantz Group (STO: LAGR-B) for over 20 years. In that time he completed 90+ acquisitions, built a portfolio of 85 niche B2B companies, and delivered 15 consecutive years of record earnings per share. No capital raises. No forced integration. No exits. The Nordic compounder model has quietly outperformed global markets for decades, and Lagercrantz is one of the longest-running, most disciplined examples of it in operation. In Part 1 of 2, Jörgen walks through the deal model behind that track record. 
     What You'll Learn
    How Lagercrantz finds companies that are not for sale, and why the first call almost never closes a deal
    How Jörgen pushes for exclusivity in weeks when most sellers are running a banker-led process
    The earnout structure Jörgen uses to keep founders motivated for three years after signing
    What he says when PE shows up at 11x and the seller is tempted to take the bigger check
    Why founders walk away from more money for legacy preservation, and the conversation that earns it
    How to close 8 to 12 deals a year without breaking pricing discipline
    If you are holding pricing discipline against private equity and want to know whether your team would do the same, DealPilot, powered by M&A Science, runs the M&A Competency Assessment so you can benchmark deal judgment before the next term sheet.
    ____________________
    This episode of M&A Science is presented by DealRoom.
    DealRoom just automated Pipeline Management with AI so you can spend less time updating deals, and more time working them.  Automatically push deal context from Outlook to DealRoom Pipeline and use AI to keep deal target data and tasks updated, so follow-ups never slip through the cracks. No manual logging. No stale pipeline data.
    See for yourself at dealroom.net/pipelineai

    ____________________

    Episode Chapters
    [00:00] Introduction
    [05:48] Jörgen's path: analyst, McKinsey, and the Bergman & Beving spinout
    [07:00] Coming back as CEO in 2006 and rebuilding from scratch
    [09:21] Buy and hold, forever: how the model actually works
    [11:21] What makes a company worth buying (and what kills it)
    [12:28] A real deal: helicopter deck safety systems
    [13:52] Who sells to Lagercrantz, and why
    [15:44] The only two things Lagercrantz adds: energy and structure
    [20:17] Finding companies that are not for sale
    [22:36] When the banker shows up: getting exclusivity early
    [23:55] Holding the line at 4-8x EBITDA when PE bids 11x
    [25:09] The legacy preservation pitch that wins without matching price
    [33:38] Earnouts that keep founders motivated for three years
    [36:17] Running 85 companies with 22 people at HQ
    [36:46] The only three functions Lagercrantz centralizes
    [37:57] The annual MD conference and the peer network behind it
    [40:13] 8 to 12 deals a year, one a month
  • M&A Science

    M&A Integration Technology: What Actually Works

    21/05/2026 | 50 min
    Jim Buckley, VP M&A Integration at Coursera | Todd Manley, VP of Corp Dev Integration at Intel | Carey Pugh is Sr. Director, M&A Corporate Integration at Ansys | Mahesh Ganesan, Sr. Director, M&A Integration at UKG

    Four integration leaders from Intel, Coursera, Ansys, and UKG debate what integration technology actually delivers versus what creates expensive overhead and where the real value leaks are. Todd Manley, Jim Buckley, Carey Pugh, and Mahesh Ganesan bring decades of deal experience to a conversation with no presentations and no curated answers.
    What You'll Learn
    Why the diligence-to-integration handoff keeps failing and what actually fixes it
    How to evaluate integration technology without getting sold on complexity
    Where AI is genuinely useful in integration today and where it is not
    How to right-size your integration effort across multiple simultaneous deals
    Why knowledge loss is the biggest value leak in M&A and what to do about it
    How to handle post-close direction shifts when the acquired team changes course
    Why post-mortems matter and why most integration teams never run them
    If you're running integration without a clear line between your workstreams and the original deal thesis, DealPilot has structured integration planning frameworks built on how practitioners at Intel, Microsoft, and UKG actually run it, so you stop rebuilding from scratch every deal. 
    ____________________
    This episode is sponsored by DealRoom
    Get Insights from 100+ M&A Practitioners
    See where M&A execution is evolving and where the competitive advantages are forming. Compare your approach to what's working for other teams. 
    Download the report: https://hubs.ly/Q03ZxRvD0
    ____________________
    Episode Chapters
    [04:16] Introductions: Todd Manley, Jim Buckley, Carey Pugh, Mahesh Ganesan
    [07:20] Integration philosophy: look back-to-forward, value drivers, keep it simple
    [09:16] Culture as the foundation and what "walking the walk" actually means
    [14:50] What separates teams that execute from teams that don't
    [17:30] The diligence handoff problem: what gets lost and why
    [23:56] Where integration technology helps and where it gets in the way
    [24:39] AI in integration: real use cases vs. early innings
    [31:02] The single source of truth problem
    [32:38] Non-tech tools: simplicity as a method (5 slides, 5 bullets, 5 words)
    [34:23] Audience Q&A: right-sizing diligence across 25 simultaneous deals
    [40:22] Audience Q&A: managing post-close autonomy flips in integration
    [43:03] Audience Q&A: sudden integration direction changes from leadership
    [45:59] Biggest value leaks in M&A integration
    [48:11] The case for pre-mortems and post-mortems
  • M&A Science

    Partner Before You Buy: The Pre-Acquisition Strategy Corp Dev Teams Skip

    14/05/2026 | 52 min
    Tomer Stavitsky is SVP and Chief Corporate Development Officer at Omnicell (NASDAQ: OMCL)
    Corp dev teams treat M&A and partnerships as separate tracks, but Tomer Stavitsky looks at them holistically. In this episode, he breaks down the partner-first approach: an acquisition framework for situations where the target isn't ready, the PE owner isn't selling, or your integration capacity isn't there. He walks us through structuring the partnership, keeping the acquisition thesis alive through execution, negotiating and defending a right of first refusal, and managing the three-way stakeholder dynamic without signaling the wrong things at the wrong time.
     
    What You'll Learn
    When partner-first is the right call and when it isn't
    How to keep the acquisition thesis alive through the partnership execution phase
    Managing the three-way dynamic between target leadership, the PE owner, and your own organization
    How to negotiate a right of first refusal and what happens when it gets tested
    Why teams pull the trigger too early and how to protect the process from internal pressure
    Applying partner-first to AI-era targets without getting caught in the hype cycle
    If you're working through a partner-first deal, the M&A Science membership has frameworks and tools built for exactly this kind of situation. Learn more at mascience.com/membership.
    ____________________
    This episode is sponsored by DealRoom
    DealRoom's Buyer-Led M&A™ Summit is Back!
    Join me at the summit on May 20, a free virtual event hosted by DealRoom covering AI, pipeline, diligence, and integration across the deal lifecycle. Sessions run 11:30 AM to 1:30 PM ET.  Register here.
    ____________________
    Episode Chapters
    [00:00] Introduction: Tomer Stavitsky's Background and the End-to-End Corp Dev View
    [08:04] Building or Rebuilding a Corp Dev Function
    [16:01] What Is the Partner-First Approach and When Does It Apply
    [21:10] Mapping the Market and Deciding Who Stays on the Watch List
    [24:13] Managing Multiple Targets Without Over-Committing
    [27:48] Using Exclusivity as a Strategic and Protective Tool
    [35:00] Managing the Three-Party Dynamic: Target Leadership, PE Owner, and Your Own Org
    [37:58] The Real Story: How a Partnership Became an Acquisition (Including the Competitive ROFR Moment)
    [42:41] The Most Common Mistake in Converting a Partnership to an Acquisition
    [44:32] Applying Partner-First to AI-Era Targets
    [49:21] What's the Craziest Thing You've Seen in M&A?
  • M&A Science

    How M&A Turns a Chemical Company Into a Tech Business

    07/05/2026 | 53 min
    Chandradev Mehta, SVP Strategy and Business Development at Hexion Inc.
    Chandradev Mehta, SVP Strategy and Business Development at Hexion Inc., breaks down how a commodity chemical company uses M&A to transform into a technology-enabled, chemistry-as-a-service business. He covers the acquisition of an AI and MarTech company, the build vs. buy vs. partner decision framework, integration planning discipline, banker selection, small deal execution, and JV governance.
    What You'll Learn
    How to build a genuine build vs. buy vs. partner framework  and when each is right
    Why buying a commercialized or near-commercialized business changes your risk profile in ways that building from scratch can't (and never will)
    How Chandradev structures must-believes to maintain valuation discipline in competitive processes
    Why integration planning needs to start at IOI, not post-close
    What separates a banker worth your time from one running a numbers game
    Why small deals are frequently harder to execute than large ones (and how to protect against organizational deprioritization)
    How to negotiate JV governance before you need to unwind it

    ____________________
    If you're building an M&A capability from scratch or trying to get your team aligned on deal fundamentals, the M&A Fundamentals Track on DealPilot covers the full deal life cycle in roughly five hours, including vocabulary, process, and both sides of the table. Access it when you become an M&A Science member.
    ____________________
    This episode is sponsored by DealRoom
    DealRoom's Buyer-Led M&A™ Summit is Back!
    Join me at the summit on May 20, a free virtual event hosted by DealRoom covering AI, pipeline, diligence, and integration across the deal lifecycle. Sessions run 11:30 AM to 1:30 PM ET. 
    Register here: https://hubs.ly/Q0496h-s0
    ____________________

    Episode Chapters
    [00:00] Introduction
    [04:41] From Investment Banking to the Principal Side
    [10:24] Using M&A to Transform Hexion
    [11:01] Build vs. Buy vs. Partner Framework
    [16:42] What Chemistry as a Service Actually Means
    [23:43] Sourcing Deals: Push and Pull Model
    [26:24] What Makes a Banker Actually Useful
    [29:12] Valuation Discipline and Must-Believes
    [36:21] Environmental Risk in Chemical Deals
    [36:46] Why Small Deals Are Harder Than They Look
    [41:21] Joint Ventures: Negotiate the Divorce First
    [43:25] Execution Principles and Stakeholder Alignment
    [47:08] Getting Deals Actionable
Más podcasts de Economía y empresa
Acerca de M&A Science
M&A Science, hosted by Kison Patel (Founder & CEO of DealRoom), is your go-to podcast for mastering the art of mergers and acquisitions. Each week, Kison and his expert guests from leading brands like Xerox, FastLap, and Cisco dig deep into real-world M&A strategies, offering actionable insights to optimize your M&A practice. Whether you're an experienced practitioner or new to the field, M&A Science provides practical advice on key topics like sourcing, due diligence, integration, divestitures, and more. With over 300 episodes, this podcast is the premier thought leadership resource designed to streamline your deal-making process. Start listening today and visit mascience.com/podcast to access over 300 episodes. Brought to you by DealRoom, the leading M&A optimization platform used by the best M&A teams around the world
Sitio web del podcast

Escucha M&A Science, Boss Tank: Ser tu propio jefe y muchos más podcasts de todo el mundo con la aplicación de radio.net

Descarga la app gratuita: radio.net

  • Añadir radios y podcasts a favoritos
  • Transmisión por Wi-Fi y Bluetooth
  • Carplay & Android Auto compatible
  • Muchas otras funciones de la app
M&A Science: Podcasts del grupo